Therapeutic Modalities for Myofascial Pain Syndromes

Myofascial pain syndromes arise from hyperirritable nodules within skeletal muscle, known as myofascial trigger points, which can provoke local and referred pain. Therapeutic approaches span pharmacological, manual and physical modalities. Pharmacological management encompasses non-steroidal anti-inflammatory drugs, muscle relaxants and local anaesthetic injections. Manual techniques include trigger point release, myofascial release and dry needling, each targeting connective tissue stiffness and neuromuscular dysfunction. Physical modalities such as ultrasound, low-level laser therapy and extracorporeal shockwave therapy aim to modulate local inflammation, enhance microcirculation and disrupt dysfunctional motor endplates. Emerging evidence supports combined multimodal regimens that integrate exercise, education and pain neuroscience to promote functional recovery and prevent recurrence. Injection therapies—ranging from local anaesthetic and corticosteroid injections to prolotherapy—offer targeted relief by chemically disrupting the trigger point milieu. The global significance of these interventions is underscored by their application in diverse settings, from sports medicine to primary care. Practical implementation requires individualised treatment plans, guided by assessment of pain intensity, pressure-pain thresholds and functional limitations. As understanding of the underlying pathophysiology advances, precision in choosing and sequencing modalities continues to improve patient outcomes and quality of life.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Therapeutic Modalities for Myofascial Pain Syndromes publication trend

The graph below shows the total number of articles in therapeutic modalities for myofascial pain syndromes across all publications each year (not limited to Nature Index journals).

Technical terms

Myofascial trigger point: A hypersensitive nodule within taut muscle fibre, eliciting local and referred pain when stimulated.

Extracorporeal shockwave therapy (ESWT): A non-invasive mechanical intervention using acoustic waves to stimulate tissue repair and modulate pain.

Low-level laser therapy (LLLT): Application of low-intensity laser light to reduce inflammation and promote cellular healing.

Ischaemic compression: Sustained manual pressure applied to a trigger point to reduce hyperalgesia and improve blood flow.

Corticosteroid trigger point injection: Local administration of corticosteroid around a myofascial trigger point to attenuate inflammation and pain.

References

1. Management of Myofascial Pain of Upper Trapezius: A Three Group Comparison Study. Global Journal of Health Science (2012).
2. Comparison of efficacy of corticosteroid injection versus extracorporeal shock wave therapy on inferior trigger points in the quadratus lumborum muscle: a randomized clinical trial. BMC Musculoskeletal Disorders (2020).
3. Efficacy and Effectiveness of Extracorporeal Shockwave Therapy in Patients with Myofascial Pain or Fibromyalgia: A Scoping Review. Medicina (2022).